Upgrade to cardiac resynchronization therapy difibrillator device of a pacemaker-dependent patient with end-stage hypertrophic cardiomyopathy

Hellenic J Cardiol. 2020 Jan-Feb;61(1):65-67. doi: 10.1016/j.hjc.2018.10.003. Epub 2018 Oct 23.

Authors

E Solomou¹, K A Gatzoulis², I Skiadas³, I Doundoulakis¹, P Arsenos¹, P Dilaveris¹, S Sideris³, D Tousoulis¹

Affiliations

¹ 1st Department of Cardiology, Hippokration General Hospital, Athens, Greece.
² 1st Department of Cardiology, Hippokration General Hospital, Athens, Greece. Electronic address: kgatzoul@med.uoa.gr.
³ State Department of Cardiology, Hippokration General Hospital, Athens, Greece.

PMID: 30366062
DOI: 10.1016/j.hjc.2018.10.003

No abstract available

Keywords: Cardiac resynchronization therapy; Hypertrophic cardiomyopathy.

Publication types

Case Reports
Letter

MeSH terms

Cardiac Electrophysiology / methods
Cardiac Resynchronization Therapy / methods*
Cardiac Resynchronization Therapy Devices
Cardiomyopathy, Hypertrophic / physiopathology
Cardiomyopathy, Hypertrophic / therapy*
Defibrillators, Implantable / adverse effects
Echocardiography / methods
Electrocardiography / methods
Humans
Male
Middle Aged
Pacemaker, Artificial / adverse effects*
Treatment Outcome
Ventricular Dysfunction, Left / diagnostic imaging
Ventricular Dysfunction, Left / physiopathology